CORT INVESTIGATION: Corcept Therapeutics Investors Should Contact Block & Leviton LLP To Potentially Recover Losses

Boston, Massachusetts--(Newsfile Corp. - January 13, 2026) - Block & Leviton is investigating Corcept Therapeutics Inc. (NASDAQ: CORT) for potential securities law violations. Investors who have lost money in their Corcept Therapeutics investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cort.

What is this all about?

Shares of Corcept Therapeutics fell more than 50% on December 31, 2025, after the Company disclosed it had received a Complete Response Letter from the FDA for relacorilant, indicating the agency could not reach a favorable risk-benefit assessment without additional evidence of effectiveness. Block & Leviton is investigating.

Who is eligible?

Anyone who purchased Corcept Therapeutics common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.

What is Block & Leviton doing?

Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

What should you do next?

If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [e-mail], or by phone at [phone].

Whistleblower?

If you have non-public information about Corcept Therapeutics, you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at [e-mail] or by phone at [phone].

Why should you contact Block & Leviton?

Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call [phone] or email [e-mail] with any questions.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: [phone]
Email: [e-mail]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/280211

The Corcept Therapeutics Stock at the time of publication of the news with a raise of +1,16 % to 32,39USD on Tradegate stock exchange (13. Januar 2026, 14:44 Uhr).